Objective. Determine the reasons for, and rates of, secondary surgical intervention through 5 years at both the index and adjacent levels in patients treated with cervical total disc replacement (TDR) or anterior cervical discectomy and fusion (ACDF). TDR patients were treated with ProDisc-C. Results. At 5 years, the ProDisc-C patients had statistically significant higher probability of no secondary surgery at the index and adjacent levels compared to the ACDF patients (97.1% vs 85.5%, p=0.0079). No reoperations in ProDisc-C patients were performed for implant breakages or device failures. For ACDF patients, the most common reason for reoperation at the index level was pseudarthrosis, and for both ACDF and TDR patients the most common reason for adjacent level surgery was recurrent neck and/or arm pain.
INTRODUCTION
Anterior cervical discectomy and fusion (ACDF) is a well-accepted treatment for radiculopathy. It allows decompression and is generally accompanied by grafting of the interspace and anterior plate fixation. Although high success rates have been associated with this procedure, problems have included pseudoarthrosis with recurrent pain at the index level, which has been reported to range from 2.9% to 6.9% per year despite high fusion rates. Hilibrand, et al, investigated 338 patients and reported that adjacent segment disease occurred at a relatively constant incidence of 2.9% per year 1 .
Cervical total disc replacement (TDR) was designed to allow neural decompression similar to that performed in an anterior cervical discectomy and fusion, to maintain motion, along with the potential to minimize adjacent segment disease.
Outcome-based, prospective randomized clinical trials for Prodisc-C, Prestige ST, and
Bryan have shown cervical TDR to be equivalent if not superior to ACDF through 2
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years. 2, 3, 4 For these three TDRs with FDA approval, longer term follow-up results have more recently become available. 5, 6, 7 Several biomechanical studies have shown increased pressure in the disc spaces adjacent to an anterior cervical fusion, as well as increased range of motion in the adjacent discs. 8, 9, 10 These studies have also shown that TDR does not produce the similar increases in adjacent level disc pressure or range of motion. These in vitro studies suggest that discs adjacent to a fusion, showing increased range of motion and increased intra discal pressure, will have a higher incidence of degeneration and potential symptoms leading to surgical intervention compared to TDR.
Multiple clinical studies have compared ACDF with cervical TDR and many have shown significant differences with increased motion at adjacent levels in the ACDF cohorts, as well as increased adjacent level degeneration.
7,11-19
More importantly, several studies comparing cervcial TDR to ACDF have a reported a 2 to 6 times higher rate of reoperation in the ACDF patients. 2, 5, 13, 17, 20 The objective of this report is to determine the rates of secondary surgical intervention at both the index and adjacent levels through 5 years, comparing patients treated with cervical TDR versus the control group, ACDF.
MATERIALS AND METHODS

Study Design
This study provides 5-year results for the investigational device exemption (IDE), who consented, are being followed at annual intervals through seven years. This analysis provides an interim report of the secondary surgeries performed through 5 years.
Institutional review board approval and patient informed consent were obtained for the initial and post approval studies.
The clinical trial identification number is NCT00291018.
This design of the IDE trial with follow-up out to 2 years has been previously well described. 1 A total 209 patients were preoperatively randomized (1:1) to ProDisc-C or ACDF, and remained blinded to their treatment assignment until immediately after surgery. After FDA approval of ProDisc-C, consenting patients in the original study are being followed at annual intervals up to 7 years as part of an FDA-regulated post approval study. This analysis provides an interim assessment of the results through 5
years. Patients were evaluated preoperatively and postoperatively at six weeks, three months, six months, 12 months and then annually up to 5 years.
Patient Population
The primary patient inclusion criteria included single level cervical disc disease causing debilitating radiculopathy from a single vertebral segment between C3 and C7, unresponsive to nonoperative treatment for at least six weeks, and a neck disability index score of 15/50 (30%) or more.
Study Interventions
The ProDisc-C is based on a ball and socket principle and is compromised of three components. There are two endplates manufactured from a cobalt chromium molybdenum alloy with a midline keel fixation, titanium plasma-sprayed coating for bony ongrowth, and an ultra-high-molecular-weight-polyethylene (UHMWPE) inlay. Figure 1 ).
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For the control group, after similar discectomy, allograft bone spacers (either surgeon cut or commercially prepared) were used and, when available, local bone was also packed around or within the allograft. No other bone substitutes were applied. An anterior cervical fixed angle plate was placed over the graft and secured in the adjacent vertebral bodies with four screws.
For both treatment groups, the standard Smith-Robinson anterior approach was used to expose the cervical spine with exposure limited to the operative level. The postoperative care regimen, including an appropriate rehabilitation program, was at the discretion of the surgeon. All patients began ambulating immediately postoperative, and many were done on an outpatient basis. A hard or soft collar was used if deemed necessary by the surgeon.
Study Outcomes
A secondary surgical intervention of any type, at any level, was considered a reoperation. Reoperations included any subsequent surgical procedure to the cervical spine, including posterior procedures such as a decompressive laminectomy or foraminotomy.
Statistical Analysis
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Based on the Cox Proportional Hazards model, the Andersen-Gill model was used to compare the rate of index and adjacent level related reoperations between treatment groups. The Andersen-Gill model is most appropriate when modeling multiple failuretime data. In this case, subjects can experience multiple reoperations at different time intervals. In that respect, it is superior to a more traditional survival analysis model, such
as Kaplan-Meier, as it uses all relevant information.
RESULTS
A total of 209 patients were randomized such that 103 received ProDisc-C and 106 receive an ACDF. Patient demographics and pre-operative characteristics have been described previously. 1 Five-year follow-up rates were 72.7% (72/99) for the ProDisc-C group and 63.5% (61/96) for the ACDF group. Patients were excluded from the analysis due to death not related to study treatment (2 ProDisc-C and 3 ACDF) and withdrawal from the long term follow-up (2 ProDisc-C and 7 ACDF).
At 5 years, the ProDisc-C patients had a statistically significantly higher probability of no secondary surgery at the index and adjacent levels compared to the ACDF patients (97.1% and 85.5% respectively with p-value = 0.0079), See Figure 2 . No reoperations in ProDisc-C patients were performed for device breakage or failure.
A total of 12 ACDF patients had reoperations with three of the 12 having more than one secondary procedure, totaling 16 reoperations. As displayed in Table 1, procedures included posterior fixation, while all others involved additional ACDF procedures. Figures 3a-3b illustrate an ACDF patient with a reoperation.
As shown in Table 2 , three ProDisc-C patients had reoperations. One involved the index level only to treat persistent pain, and two incorporated the index and adjacent levels for persistent pain and adjacent level degeneration. The ProDisc-C was removed in two patients and the levels converted to anterior fusions. One ProDisc-C was left intact with a posterior foraminotomy and fusion with stabilization. Figures 4a-4b illustrate a ProDisc-C patient with a reoperation.
DISCUSSION
At the inception of the ProDisc-C IDE study, safety and efficacy of the TDR technology compared to the gold standard of an ACDF were the main study goals. All three studies have shown an increased reoperation rate in the ACDF control cohort. At a minimum 2 year follow-up, Murrey et al. 2 reported a reoperation rate of 8.5% in the fusion group and 1.9% in the ProDisc-C group. Anderson et al. 20 reported significantly more reoperations in the fusion group compared to the Bryan TDR cohort. Burkus et al. 5 reported the results of the Prestige TDR and showed significantly less reoperations in the TDR group. Zhang et al. reported on a randomized trial comparing 60 fusion patients to 60 Bryan TDR patients and reported a 4 times increased reoperation rate in the fusion group.
In the longer-term follow-up of the two patient groups in the prospective randomized IDE study comparing ProDisc-C to ACDF, the reoperation rates differed significantly between the fusion control and TDR patient cohorts. The ACDF patients were observed to have a 5 times higher rate of reoperations. The most common reason for reoperation at the index level in the fusion cohort was pseudarthrosis, and in one patient a lift off of the plate causing swallowing difficulties which required revision surgery. Half of the reoperations in the ACDF patients were performed for adjacent level degeneration. Among the ProDisc-C patients, no reoperations were performed for implant breakages or device failures. All reoperations in this group were for recurring pain, at either index or adjacent levels.
CONCLUSION
The results of this 5-year follow-up analysis are consistent with the published biomechanical and clinical studies comparing cervical TDR with ACDF demonstrating a significant sparing effect of TDR on the adjacent level. These patient cohorts will be followed for an additional two years, so that additional data will be generated with even longer term follow-up. 
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